Cannabidiol safety and effects for social anxiety
About this title
Read the official source — NCT05600114This study evaluated the safety and effectiveness of Cannabidiol oral solution for people with anxiety.
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of Cannabidiol oral solution for people with anxiety.
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
- Listed locations
- Encino and 16 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 239
- Sponsor
- EmpowerPharm Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT05600114
- Official title
Show the full official title
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study, Evaluating the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution in Subjects With Social Anxiety Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Encino · Lemon Grove · Los Alamitos
14 more locations
- Oceanside
- San Jose
- Jacksonville
- Lauderhill
- Maitland
- Orlando
- Chicago
- Cedarhurst
- New York
- Rochester
- Oklahoma City
- Portland
- Wichita Falls
- Bellevue
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of Cannabidiol oral solution for people with anxiety.
Who is behind this study?
The study sponsor is EmpowerPharm Inc.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol oral solution and Placebo.
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
